Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Visionary Holdings (Nasdaq: GV) is a technology-driven multinational enterprise that has pivoted significantly into the high-tech healthcare and biotechnology sectors, specifically focusing on regenerative medicine and anti-aging solutions. Through its subsidiary, Visionary Health Technology Group, the company develops and commercializes a portfolio of cell therapy and biological products, including its flagship RAMU anti-aging line. The company operates a multi-city commercialization network in China, with research and sales hubs in cities like Hangzhou, Nanjing, and Qingdao. Visionary Holdings integrates AI applications with biotechnology to drive innovation in cellular rejuvenation and aesthetic treatments, aiming to establish a chain of health management centers across Asia and North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Vision.